Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Stress turns hair white by depleting color-giving cells in hair follicles through a specific neurotransmitter related to the body's stress response.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

Stress in hair follicle cells increases certain immune-related proteins, which might contribute to hair loss conditions.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Alopecia areata in elderly people is usually mild and responds well to treatment.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Squaric acid dibutylester effectively treats alopecia areata.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.